Digital health and genomics 'should form new pillars of life science industry'

Three new life science industries should be established, including genomics and digital health, to keep the UK at the forefront of the field, a professor of medicine has said. Speaking at the annual lecture of the Medicines and Healthcare products Regulatory Agency (MHRA), John Bell, Regius Professor of Medicine at the University of Oxford, said the new industries would be critical to the UK continuing to lead in the field of life sciences. The three industries, genomics; digital health; and early diagnosis will come with their own regulatory challenges, Bell told 200 healthcare leaders at the event. "Innovation in regulation fundamentally underpins the entire sector and is vital for economic growth," he said. "As the largest and most innovative regulator in Europe, the MHRA is crucial to the UK's strategy."